Novel pharmacological therapies for the treatment of AIDS-related Kaposi’s sarcoma

Author： Cattelan Anna Maria   Trevenzoli Marco   Aversa Savina Maria Lucia  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.5, 2004-05, pp. : 501-513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-12 appears to be efficacious in patients with AIDS-related Kaposi's sarcoma

By  

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Polyethylene Glycol-Liposomal Doxorubicin: A Review of its Use in the Management of Solid and Haematological Malignancies and AIDS-Related Kaposi's Sarcoma

By Sharpe M.   Easthope S.E.   Keating G.M.   Lamb H.M.  

Drugs, Vol. 62, Iss. 14, 2002-01 ,pp. : 2089-2126

Adis International

Access to resources Recommend Favorite

Kaposi’s sarcoma-associated herpesvirus and innate immunity

By West John A   Damania Blossom  

Future Virology, Vol. 5, Iss. 2, 2010-03 ,pp. : 185-196

Future Medicine

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin: A Review of its use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi's Sarcoma

By Duggan Sean T.   Keating Gillian M.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2531-2558

Adis International

Access to resources Recommend Favorite

HAART is the centre of graduated systemic treatment of AIDS-associated Kaposi's sarcoma

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 8, 2005-08 ,pp. : 14-17

Adis International

Access to resources Recommend Favorite